A ground-breaking study on Mistica written by Synergy Medical Advisory Board member Dr. Norm Shealy was recently approved for publication in The Journal of Subtle Energies and Energy Medicine.
The test group consisted of 38 healthy adults ranging in age from 24 to 52 years old. Participants were first tested for urinary malondialdehyde (MDA) using the OxiScore test kits. MDA is a by-product of free radical damage in the cell, and urine measurement of MDA is the easiest way to measure for free radical production.
Participants were given two bottles of Mistica and instructed to take two tablespoons twice daily. After three weeks, participants returned for a repeat MDA test.
The results powerfully supported Mistica’s antioxidant abilities. On average there was a 43 percent overall reduction of free radicals in the participants.
Mistica comprises a core part of innovative Synergy’s V3 System, which is like nothing else on the market. The power of V3 lies in how its three products, Core Greens, Mistica, and ProArgi-9 Plus, work together to build a foundation for good health, boost immunity, and enhance the circulatory system for long-term wellness.